Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis

被引:118
作者
Jang S.-J. [1 ]
Kim J.-D. [1 ]
Cha S.-S. [2 ]
机构
[1] Department of Orthopaedic Surgery, Kosin University, Gospel Hospital, Seo-gu, Busan 602-030
[2] Department of Diagnostic Radiology, Inje University, Busan Paik Hospital, Busan
关键词
Duration of effect; Osteoarthritis; Patellofemoral joint; Platelet-rich plasma;
D O I
10.1007/s00590-012-1037-5
中图分类号
学科分类号
摘要
The aims of this study were to analyze the range of cartilage damage and patellofemoral joint (PFJ) degeneration in degenerative osteoarthritis (OA) and determine the duration for the positive effects of platelet-rich plasma (PRP) injection. This study included 65 patients suffering from OA that were treated with intra-articular PRP injection. The patients were prospectively evaluated at 1, 3, 6, 9, and 12 months after the procedure using a visual analogue scale (VAS) score and an International Knee Documentation Committee (IKDC) score. Clinical improvement in the average VAS score from 7.4 before the procedure to 4.2 at 6 months post-procedure had been reported, but the symptoms tended to deteriorate to 5.0 1 year after injection. The IKDC score also showed statistical significance (P < 0.05). Patients reported relapsed pain 8.8 months after the procedure. Developing degeneration according to the Kellgren-Lawrence grade reduced the clinical effects of PRP (P < 0.05) and also accelerated the time for feeling relapsed pain (P < 0.05). There was a statistically significant negative correlation between patient age and the PRP potential in the VAS score (slope = 0.1667) and IKDC score (slope = 1.3333). The presence of PFJ degeneration is expected to produce a worse outcome (P < 0.05). While intra-articular PRP injection can be used for the treatment of early OA, increasing age, and developing degeneration result in a decreased potential for PRP injection therapy. © 2012 Springer-Verlag.
引用
收藏
页码:573 / 580
页数:7
相关论文
共 29 条
[1]
Buckwalter J.A., Mankin H.J., Articular cartilage. Part II: Degeneration and osteoarthrosis, repair, regeneration, and transplantation, Journal of Bone and Joint Surgery - Series A, 79, 4, pp. 612-632, (1997)
[2]
Gobbi A., New possibilities for cartilage repair, Eur Musculoskelet Rev, 5, 2, pp. 64-68, (2010)
[3]
Buckwalter J.A., Brown T.D., Joint injury, repair, and remodelling: Roles in post-traumatic osteoarthritis, Clinical Orthopaedics and Related Research, 423, pp. 7-16, (2004)
[4]
Tran-Khanh N., Hoemann C.D., McKee M.D., Henderson J.E., Buschmann M.D., Aged bovine chondrocytes display a diminished capacity to produce a collagen-rich, mechanically functional cartilage extracellular matrix, Journal of Orthopaedic Research, 23, 6, pp. 1354-1362, (2005)
[5]
Pietrzak W.S., Eppley B.L., Platelet rich plasma: Biology and new technology, J Craniofac Surg, 16, 6, pp. 1043-1054, (2007)
[6]
Frisbie D.D., Kawcak C.E., Werpy N.M., Park R.D., Mcllwraith C.W., Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis, American Journal of Veterinary Research, 68, 3, pp. 290-296, (2007)
[7]
Baltzer A.W., Moser C., Jansen S.A., Krauspe R., Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis, Osteoarthr Cartil, 17, pp. 152-160, (2009)
[8]
Filardo G., Kon E., Buda R., Timoncini A., Di Martino A., Cenacchi A., Fornasari P.M., Giannini S., Marcacci M., Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis, Knee Surg Sports Traumatol Arthrosc, 19, 4, pp. 528-535, (2011)
[9]
Kon E., Mandelbaum B., Buda R., Filardo G., Delcogliano M., Timoncini A., Fornasari P.M., Giannini S., Marcacci M., Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: From early degeneration to osteoarthritis, Arthroscopy, 27, 11, pp. 1490-1501, (2011)
[10]
Kellgren J.H., Lawrence J.S., Radiological assessment of osteoarthritis, Ann Rheum Dis, 16, pp. 494-501